TADEUSZ MAJCHRZAK: Open Payments
NPI 1720061070 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,810 in 32 payments from 9 companies in 2025. Trend: 2023 $1,144 · 2024 $2,105 · 2025 $1,810
Food & beverage: $1,810
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $1,169 |
| Stryker Corporation | 1 | $167 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| Abbott Laboratories | 1 | $125 |
| ABIOMED | 1 | $123 |
| SCILEX PHARMACEUTICALS INC. | 2 | $37 |
| ABBVIE INC. | 2 | $29 |
| Gilead Sciences, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
Products named: AIRSUPRA, FARXIGA, FLOWTRIEVER CATHETER, S, BREZTRI, PENMENVY, FREESTYLE LIBRE 3, ZTLido, ELYXYB - CELECOXIB.
Industry payments across NJ — which companies pay providers there.
